{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:39:45Z","timestamp":1792802385646,"version":"4.5.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Otsuka Toshimi Scholarship Foundation","id":[{"id":"https:\/\/ror.org\/056eg3t49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198224","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:37:29Z","timestamp":1527860249000},"page":"e0198224","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model"],"prefix":"10.1371","volume":"13","author":[{"given":"Xieyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-2297","authenticated-orcid":true,"given":"Takahito","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyunbold","family":"Lamid-Ochir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Nguyen-Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"RL Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.3747\/co.22.2566","article-title":"Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review","volume":"22","author":"PM Ellis","year":"2015","journal-title":"Curr Oncol"},{"issue":"30","key":"ref4","doi-asserted-by":"crossref","first-page":"50209","DOI":"10.18632\/oncotarget.16854","article-title":"Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer","volume":"8","author":"X Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0014-4827(02)00104-0","article-title":"ErbB-targeted therapeutic approaches in human cancer","volume":"284","author":"CL Arteaga","year":"2003","journal-title":"Exp Cell Res"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"TJ Lynch","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10120-013-0288-0","article-title":"Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection","volume":"17","author":"HS Oh","year":"2014","journal-title":"Gastric Cancer"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1158\/1078-0432.CCR-14-3284","article-title":"Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer","volume":"21","author":"EL Rosenthal","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"16","key":"ref9","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-15-0348","article-title":"PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging","volume":"21","author":"LK van Dijk","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"SS Gambhir","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5603\/NMR.2015.0009","article-title":"18F-FDG-PET\/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up","volume":"18","author":"S Karunanithi","year":"2015","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","article-title":"Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study","volume":"86","author":"K Cetin","year":"2014","journal-title":"Lung Cancer"},{"issue":"29","key":"ref13","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1016\/j.biomaterials.2011.06.024","article-title":"A review of NIR dyes in cancer targeting and imaging","volume":"32","author":"S Luo","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.biotechadv.2016.04.001","article-title":"Indocyanine green delivery systems for tumour detection and treatments","volume":"34","author":"EP Porcu","year":"2016","journal-title":"Biotechnol Adv"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00595-015-1158-7","article-title":"Recent advances in near-infrared fluorescence-guided imaging surgery using indocyanine green","volume":"45","author":"T Namikawa","year":"2015","journal-title":"Surg Today"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1021\/bc2002715","article-title":"Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate","volume":"22","author":"T Nakajima","year":"2011","journal-title":"Bioconjug Chem"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/0008-5472.CAN-08-3116","article-title":"In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green","volume":"69","author":"M Ogawa","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/bc400050k","article-title":"Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes","volume":"24","author":"K Sano","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21037\/acs.2016.03.08","article-title":"Overview of uniportal video-assisted thoracic surgery (VATS): past and present","volume":"5","author":"JM Reinersman","year":"2016","journal-title":"Ann Cardiothorac Surg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/jovs.2016.02.14","article-title":"Video-assisted thoracic surgery experience of calcified lymph nodes for lingular sparing lobectomy","volume":"2","author":"Q Ma","year":"2016","journal-title":"J Vis Surg"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e14117","DOI":"10.1371\/journal.pone.0014117","article-title":"Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression","volume":"5","author":"KE Ware","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"WD Dupont","year":"1990","journal-title":"Control Clin Trials"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr3167","article-title":"In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores","volume":"14","author":"K Sano","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial","volume":"290","author":"MG Kris","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2310\/7290.2009.00031","article-title":"Toxicity of organic fluorophores used in molecular imaging: literature review","volume":"8","author":"R Alford","year":"2009","journal-title":"Mol Imaging"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.12-5-577","article-title":"FDA drug approval summary: panitumumab (Vectibix)","volume":"12","author":"RM Giusti","year":"2007","journal-title":"Oncologist"},{"issue":"15 Pt 2","key":"ref27","doi-asserted-by":"crossref","first-page":"s4597","DOI":"10.1158\/1078-0432.CCR-07-0335","article-title":"Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab","volume":"13","author":"MA Socinski","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/07357907.2017.1344698","article-title":"First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)","volume":"35","author":"DR Spigel","year":"2017","journal-title":"Cancer Invest"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.lungcan.2009.05.002","article-title":"Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study","volume":"67","author":"SB Yoo","year":"2010","journal-title":"Lung Cancer"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-015-3542-9","article-title":"Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer","volume":"153","author":"U Toh","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"ref31","first-page":"110","article-title":"Epidermal growth factor receptor in non-small cell lung cancer","volume":"4","author":"CN Prabhakar","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Z Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"69","key":"ref33","doi-asserted-by":"crossref","first-page":"113373","DOI":"10.18632\/oncotarget.23009","article-title":"Cell-surface marker discovery for lung cancer","volume":"8","author":"AS Cohen","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"ref34","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1200\/JCO.2012.45.6095","article-title":"Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives","volume":"31","author":"J Mazieres","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T20:24:54Z","timestamp":1604348694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198224"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198224","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}